The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

How Dementia Affects the Brain's Ability ... Machine Learning Reveals Behaviors Linked With Early Alzheimer's, Points to New Treatments Nov. 26, 2024 — Scientists used a new video-based machine ...

Researchers from Oxford’s Institute of Population Ageing and the University of Manchester, and Tufts University have found ...

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Discover the surprising link between herpes and Alzheimer's disease. Find out how the common herpes simplex virus may play a ...

A WORD on the tip of the tongue or a forgotten birthday – everyone has occasional memory blanks. While forgetting things ...